Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1829635 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $5.25Day +5.85%Mkt cap $5M1Y −52.9%Off 52W high −75.0%Vol (1Y) 97.8%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,133 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest3.6% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)+0.49% |
| Top-10 13F concentration100.0% |
| Next report (est.)2026-08-15 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$40.4M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−23.1% |
| 1Y−52.9% |
| 3Y−100.0% |
| 5Y−100.0% |
| Since incept. (ann.)−93.4% |
Total return through 2026-07-30 · series begins 2021-07-12. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)97.8% |
| Ann. volatility (3Y)165.7% |
| Sharpe (1Y)−0.37 |
| Sharpe (3Y)−1.09 |
| Max drawdown (1Y)−70.1% |
| Max drawdown (3Y)−100.0% |
| Beta (3Y vs SPY)3.90 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 12,740 | $109,690 | 1.39% | new |
| UBS Group AG | 8,295 | $71,420 | 0.90% | +179.9% |
| VANGUARD CAPITAL MANAGEMENT LLC | 6,545 | $56,352 | 0.71% | new |
| VANGUARD FIDUCIARY TRUST CO | 2,982 | $25,675 | 0.33% | new |
| Tower Research Capital LLC (TRC) | 228 | $1,963 | 0.02% | −74.3% |
| WELLS FARGO & COMPANY/MN | 55 | $474 | 0.01% | new |
| SBI Securities Co., Ltd. | 12 | $103 | 0.00% | +20.0% |
| ROYAL BANK OF CANADA | 8 | $0 | 0.00% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | −$21.28 | — | — | — |
| 2025-09-30 | 2025-11-14 | −$5.82 | — | — | — |
| 2025-06-30 | 2025-08-14 | −$5.13 | — | — | — |
| 2025-03-31 | 2025-05-14 | — | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-15 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
